Indraprastha Medical Corporation Limited

Medical Care Facilities

Prices are adjusted according to historical splits.

Indraprastha Medical Corporation Limited Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
₹8.08 billion
Book Value:
Revenue TTM:
₹11.09 billion
Operating Margin TTM:
Gross Profit TTM:
₹4.82 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Indraprastha Medical Corporation Limited had its IPO on under the ticker symbol INDRAMEDCO.

The company operates in the Healthcare sector and Medical Care Facilities industry. Indraprastha Medical Corporation Limited has a staff strength of 0 employees.

Stock update

Shares of Indraprastha Medical Corporation Limited opened at ₹90.4 at the start of the last trading session i.e. 2023-05-28.

The stocks traded within a range of ₹87.5 - ₹92.25, and closed at ₹87.9.

This is a -1.29% slip from the previous day's closing price.

A total volume of 166,635 shares were traded at the close of the day’s session.

In the last one week, shares of Indraprastha Medical Corporation Limited have increased by +5.65%.

Indraprastha Medical Corporation Limited's Key Ratios

Indraprastha Medical Corporation Limited has a market cap of ₹8.08 billion, indicating a price to book ratio of 2.2337 and a price to sales ratio of 0.7878.

In the last 12-months Indraprastha Medical Corporation Limited’s revenue was ₹11.09 billion with a gross profit of ₹4.82 billion and an EBITDA of ₹1.61 billion. The EBITDA ratio measures Indraprastha Medical Corporation Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Indraprastha Medical Corporation Limited’s operating margin was 10.96% while its return on assets stood at 14.93% with a return of equity of 24.44%.

In Q1, Indraprastha Medical Corporation Limited’s quarterly earnings growth was a positive 30.5% while revenue growth was a positive 29.2%.

Indraprastha Medical Corporation Limited’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at ₹9.25 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Indraprastha Medical Corporation Limited’s profitability.

Indraprastha Medical Corporation Limited stock is trading at a EV to sales ratio of 0.5741 and a EV to EBITDA ratio of 3.9802. Its price to sales ratio in the trailing 12-months stood at 0.7878.

Indraprastha Medical Corporation Limited stock pays annual dividends of ₹0 per share, indicating a yield of 2.84% and a payout ratio of 34.56%.

Balance sheet and cash flow metrics

Total Assets
₹5.55 billion
Total Liabilities
₹1.30 billion
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Indraprastha Medical Corporation Limited ended 2023 with ₹5.55 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹5.55 billion while shareholder equity stood at ₹3.79 billion.

Indraprastha Medical Corporation Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹1.30 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹522.60 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Indraprastha Medical Corporation Limited’s total current assets stands at ₹2.23 billion while long-term investments were ₹0 and short-term investments were ₹832.70 million. Its net receivables were ₹682.40 million compared to accounts payable of ₹981.80 million and inventory worth ₹84.50 million.

In 2023, Indraprastha Medical Corporation Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Indraprastha Medical Corporation Limited paid ₹0.35 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Indraprastha Medical Corporation Limited stock is currently trading at ₹87.9 per share. It touched a 52-week high of ₹94.05 and a 52-week low of ₹94.05. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹82.58 and 200-day moving average was ₹77.86 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5983.4% of the company’s stock are held by insiders while 2.4% are held by institutions.

Frequently Asked Questions About Indraprastha Medical Corporation Limited

The stock symbol (also called stock or share ticker) of Indraprastha Medical Corporation Limited is INDRAMEDCO

The IPO of Indraprastha Medical Corporation Limited took place on

Similar Industry Stocks (Medical Care Facilities)

Last Price
Seapeak LLC (SEAL-PA)

Most Active

Last Price
Tesla Inc (TSLA)

Top Gainers

Last Price
Boxed Inc (BOXD)

Top Losers

Last Price


Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology, ENT, cosmetic & plastic surgery, dental surgery, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company was incorporated in 1988 and is based in New Delhi, India.